I’m well aware of the Bapineuzumab program and the respective economic shares of the program owned by PFE, JNJ, and ELN. The biomedreports.com blurb you posted in #msg-53531204 is spam under the guise of being news, which is par for the course for that rag.
Market Data 
Markets 
AI
